Overall Survival Benefit of Ixazomib, Lenalidomide and Dexamethasone (IRD) over Lenalidomide and Dexamethasone (RD) in RRMM Patients Treated in Routine Clinical Practice: Results from the Czech Registry of Monoclonal Gammopathies (RMG)
暂无分享，去创建一个
R. Hájek | T. Jelínek | M. Mistrik | I. Špička | J. Minařík | P. Jindra | J. Radocha | M. Sýkora | P. Kessler | L. Pour | P. Pavlíček | T. Skácel | T. Pika | J. Bačovský | K. Machálková | V. Maisnar | L. Brožová | M. Štork | L. Stejskal | J. Straub | A. Jungová | J. Ullrychová | P. Krhovská | H. Plonkova | Adriana Heindorfer | Lenka Capkova